| 216457 | NDA | HERON THERAPS INC | | 001 | APONVIE | EMULSION;INTRAVENOUS | 32MG/4.4ML (7.2MG/ML) | APREPITANT | 2022-09-16 | Prescription | Yes |
| 211988 | NDA | HERON THERAPS INC | | 001 | ZYNRELEF KIT | SOLUTION, EXTENDED RELEASE;PERIARTICULAR | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | BUPIVACAINE; MELOXICAM | 2021-05-12 | Discontinued | No |
| 002 | ZYNRELEF KIT | SOLUTION, EXTENDED RELEASE;PERIARTICULAR | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | BUPIVACAINE; MELOXICAM | 2021-05-12 | Prescription | Yes |
| 003 | ZYNRELEF KIT | SOLUTION, EXTENDED RELEASE;PERIARTICULAR | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | BUPIVACAINE; MELOXICAM | 2021-05-12 | Discontinued | No |
| 004 | ZYNRELEF KIT | SOLUTION, EXTENDED RELEASE;PERIARTICULAR | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | BUPIVACAINE; MELOXICAM | 2021-05-12 | Prescription | Yes |
| 209296 | NDA | HERON THERAPS INC | | 001 | CINVANTI | EMULSION;INTRAVENOUS | 130MG/18ML (7.2MG/ML) | APREPITANT | 2017-11-09 | Prescription | Yes |
| 022445 | NDA | HERON THERAPS INC | | 001 | SUSTOL | INJECTABLE;SUBCUTANEOUS | 10MG/0.4ML (10MG/0.4ML) | GRANISETRON | 2016-08-09 | Prescription | Yes |